Kenneth L. Horton, EVP & Chief Legal Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 36,000 shares at $111.33 ($4.1M) on 2014-09-30, disclosed to the SEC on 2014-10-01.
Scheduled sale ($4.1M) by EVP & Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $111.33 | 4,713 | $525K | 12.9% |
| 2 | $112.22 | 14,286 | $1.6M | 39.5% |
| 3 | $113.10 | 9,601 | $1.1M | 26.8% |
| 4 | $113.91 | 7,400 | $843K | 20.8% |
| Total | $112.69 avg | 36,000 | $4.1M | 100% |
| Filing → |
| VRTX | SELL | 2013-12-12 | $297K | — | Filing → |
| VRTX | SELL | 2013-07-10 | $146K | — | Filing → |